Matching Items (4)
Filtering by

Clear all filters

160806-Thumbnail Image.png
Description
My thesis aims to examine how partisan politics and politicization of women’s health issues adversely impacts the health and wellbeing of women. I will explore this topic within the broader context of partisanship, morality, feminism, and social justice in an attempt to dissect the arguments propagated by both the pro-life

My thesis aims to examine how partisan politics and politicization of women’s health issues adversely impacts the health and wellbeing of women. I will explore this topic within the broader context of partisanship, morality, feminism, and social justice in an attempt to dissect the arguments propagated by both the pro-life and pro-choice spheres. Political polarization results in limitations for reproductive health resources for women, particularly low-income and minority women who rely on government-funded healthcare to meet their needs. Moreover, reducing women’s healthcare decision-making opportunities not only has a destructive impact on their health and financial security, but also poses significant human rights implications concerning bodily autonomy and gender equality. Through the literature review, I intend on highlighting the role of conservative politics in diminishing available services, to the detriment of women, particularly low-income and marginalized women. I plan to demonstrate this hypothesis through a literature review, analysis of Roe v. Wade, and a review of the historical trajectory that illuminates factors related to the availability and accessibility of reproductive resources. Lastly, I will critique the political narratives pushed by both liberal and conservative media and highlight the need for a comprehensive reproductive justice framework for achieving positive SHRH outcomes.
Created2021-05
173598-Thumbnail Image.png
Description

Katharine Dexter McCormick, who contributed the majority of funding for the development of the oral contraceptive pill, was born to Josephine and Wirt Dexter on 27 August 1875 in Dexter, Michigan. After growing up in Chicago, Illinois, she attended the Massachusetts Institute of Technology (MIT), where she graduated in 1904

Katharine Dexter McCormick, who contributed the majority of funding for the development of the oral contraceptive pill, was born to Josephine and Wirt Dexter on 27 August 1875 in Dexter, Michigan. After growing up in Chicago, Illinois, she attended the Massachusetts Institute of Technology (MIT), where she graduated in 1904 with a BS in biology. That same year, she married Stanley McCormick, the son of Cyrus McCormick, inventor and manufacturer of the mechanized reaper. Katharine's father was a prominent Chicago lawyer, so this marriage created the accumulation of great wealth and power. Her primary contribution to society was her commitment to reproductive reform.

Created2007-11-08
173659-Thumbnail Image.png
Description

Plan B is a progestin-only emergency contraceptive pill (ECP) that can be taken within seventy-two hours of unprotected sex in order to prevent an unwanted pregnancy. Plan B was created in response to the United States Food and Drug Administration's (US FDA) 1997 request for new drug applications (NDAs) for

Plan B is a progestin-only emergency contraceptive pill (ECP) that can be taken within seventy-two hours of unprotected sex in order to prevent an unwanted pregnancy. Plan B was created in response to the United States Food and Drug Administration's (US FDA) 1997 request for new drug applications (NDAs) for a dedicated ECP product, and was approved for sales in the US in 1999. Duramed, a subsidiary of Barr Pharmaceuticals, manufactures Plan B for The Women's Capital Corporation (WCC), which owns the patent for Plan B. This technology is important in part because it expands women's reproductive rights by giving them greater control over their fertility. The mechanism of action of Plan B also raises questions about the moral status of the zygote.

Created2008-09-04
173535-Thumbnail Image.png
Description

Enovid was the first hormonal birth control pill. G. D. Searle and Company began marketing Enovid as a contraceptive in 1960. The technology was created by the joint efforts of many individuals and organizations, including Margaret Sanger, Katharine McCormick, Gregory Pincus, John Rock, Syntex, S.A. Laboratories, and G.D. Searle and

Enovid was the first hormonal birth control pill. G. D. Searle and Company began marketing Enovid as a contraceptive in 1960. The technology was created by the joint efforts of many individuals and organizations, including Margaret Sanger, Katharine McCormick, Gregory Pincus, John Rock, Syntex, S.A. Laboratories, and G.D. Searle and Company Laboratories. Although there were many pieces and contributors to the final product, it was first conceived of and created by Gregory Pincus and Margaret Sanger through the Worcester Foundation in Worcester, Massachusetts, and was distributed by Searle, located in Chicago. This technology is important to the history of embryology because it changed the way people viewed birth control and revolutionized women's birth control methods. There is an extensive literature on the cultural and societal effects of the pill; for example, the effect it had on women's health care and how it changed perceptions of female sexuality.

Created2009-01-20